Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

FSHD myotubes with different phenotypes exhibit distinct proteomes.

Tassin A, Leroy B, Laoudj-Chenivesse D, Wauters A, Vanderplanck C, Le Bihan MC, Coppée F, Wattiez R, Belayew A.

PLoS One. 2012;7(12):e51865. doi: 10.1371/journal.pone.0051865. Epub 2012 Dec 18.

2.

Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?

Richards M, Coppée F, Thomas N, Belayew A, Upadhyaya M.

Hum Genet. 2012 Mar;131(3):325-40. doi: 10.1007/s00439-011-1100-z. Epub 2011 Oct 9. Review.

PMID:
21984394
3.

Deciphering transcription dysregulation in FSH muscular dystrophy.

Ehrlich M, Lacey M.

J Hum Genet. 2012 Aug;57(8):477-84. doi: 10.1038/jhg.2012.74. Epub 2012 Jun 21. Review.

4.

Facioscapulohumeral muscular dystrophy: molecular pathological advances and future directions.

Statland JM, Tawil R.

Curr Opin Neurol. 2011 Oct;24(5):423-8. doi: 10.1097/WCO.0b013e32834959af. Review.

PMID:
21734574
5.

A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy.

Gatica LV, Rosa AL.

Neuromuscul Disord. 2016 Dec;26(12):844-852. doi: 10.1016/j.nmd.2016.09.015. Epub 2016 Sep 19. Review.

PMID:
27816329
6.

Facioscapulohumeral muscular dystrophy: do neurotrophins play a role?

Angelucci F, Colantoni L.

Muscle Nerve. 2010 Jan;41(1):120-7. doi: 10.1002/mus.21505. Review.

PMID:
19813193
7.

Molecular genetics of facioscapulohumeral muscular dystrophy (FSHD).

Fisher J, Upadhyaya M.

Neuromuscul Disord. 1997 Jan;7(1):55-62. Review.

PMID:
9132141
8.

[Progress in researches on the molecular genetics of facioscapulohumeral muscular dystrophy].

Su Q, Zhang C.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001 Oct;18(5):398-401. Review. Chinese.

PMID:
11592052
9.

Facioscapulohumeral dystrophy: the path to consensus on pathophysiology.

Tawil R, van der Maarel SM, Tapscott SJ.

Skelet Muscle. 2014 Jun 10;4:12. doi: 10.1186/2044-5040-4-12. eCollection 2014. Review.

10.

Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy.

Bao B, Maruyama R, Yokota T.

Intractable Rare Dis Res. 2016 Aug;5(3):168-76. doi: 10.5582/irdr.2016.01056. Review.

Supplemental Content

Support Center